Solasta Bio

Glasgow, United Kingdom Founded: 2020 • Age: 6 yrs
Provider of pest control services and inputs

About Solasta Bio

Solasta Bio is an Agriculture company based in Glasgow (United Kingdom) founded in 2020 by Paul Bernasconi, Julian Dow, and Shireen Davies. Provider of pest control services and inputs. Solasta Bio has raised $20.76 million across 4 funding rounds from investors including University of Glasgow, Corteva Agriscience and Scottish Enterprise. The company has 19 employees. Its chief executive, as recorded, is Shireen Davies. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Biologicals. Its legal entity is SOLASTA BIO LIMITED.

Company details

Solasta Bio was founded in 2020 in Glasgow, United Kingdom. Operations focus on the biotechnology sector for agriculture. Insect control peptides are developed to disrupt functions in target pest species. Beneficial insects and vertebrates are left unaffected by these solutions. Pest control services and related inputs are offered through this platform to support sustainable management practices.

  • Headquarters Glasgow, United Kingdom
  • Employees 19
  • Founders Paul Bernasconi, Julian Dow, Shireen Davies
  • Sectors
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website solastabio.com
  • Social LinkedIn
  • Legal Name Solasta Bio Limited
  • Date of Incorporation 19 May, 2020
  • Jurisdiction GLASGOW, SCOTLAND
Operational Areas
Key Metrics
  • Total Equity Funding
    $20.76M (USD)

    in 4 rounds

  • Latest Funding Round
    $14M (USD), Series A

    Sep 2024

  • Investors
  • Employee Count
    19

Funding Insights of Solasta Bio

Solasta Bio has successfully raised a total of $20.76M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $20.76M
  • Total Rounds 4
  • Last Round Series A β€” $14M
  • First Round $1.8M

    (Aug 2021)

  • Investors Count 13

All 4 funding rounds of Solasta Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$14MSeries A–Forbion, FMC
Mar 2024$1MGrant––
Apr 2023$4.96MSeed–The Yield Lab
Aug 2021$1.8MSeed–Scottish Investment Bank, SIS Ventures
Valuation history

13 investors in total: 13 institutional.

Investors in Solasta Bio

Solasta Bio has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Glasgow, Corteva Agriscience and Scottish Enterprise.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on lifescience and healthcare sectors
forbion.comNaarden, Netherlands
Venture capital is provided by Cavallo Ventures in multiple sectors.
cavallovc.comSan Francisco, United States
Impact investments are made in world-changing entrepreneurial ventures.
2014rubio.vcAmsterdam, Netherlands
Early-stage innovations are funded by UKI2S across key sectors.
ukinnovationscienceseedfund.co.ukManchester, United Kingdom
Venture capital fund focused on social impact companies
sisventures.comEdinburgh, United Kingdom
Venture capital firm & accelerator focused on early-stage companies
2014theyieldlab.comSt. Louis, United States
Investment support is provided for agritech startups in the UK.
camagritech.comCambridge, United Kingdom
FMC Corporation is engaged in agricultural sciences and crop protection.
1883fmc.comPhiladelphia, United States
Manufacturer and supplier of agricultural farm inputs
2017corteva.comWilmington, United States
Business development and leadership training programs are offered to companies.
1991scottish-enterprise.comGlasgow, United Kingdom
Premium access

Investor details for Solasta Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Solasta Bio

12 people are tracked at Solasta Bio (5 in leadership, 7 in team); the tracked headcount is 19.

NameRoleGroup
Paul Bernasconi
Co-FounderLeadership
Julian Dow
Co-FounderLeadership
Shireen Davies
Co-Founder & CEOLeadership
Daphne Preuss
Chief Business OfficerLeadership
Paula Pinto
Chief Strategy OfficerLeadership
Yousef Abul-Haija
Research And Development ManagerTeam
Lewis Archibald
Team Leader (Chemistry)Team
Selma Crecente García
Scientist (Chemistry)Team
Pragya Shukla
Operations ManagerTeam
Bea Monteagudo
Team Leader - EntomologyTeam
Hugh Nicholson, PhD
Scientific Project ManagerTeam
Edward Smith
Cell TechnicianTeam
Premium access

Complete people profiles for Solasta Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Solasta Bio

3 dated milestones of Solasta Bio across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Solasta Bio is founded.
  2. Funding First funding round of $1.8M.
  3. Funding Latest funding round, Series A, of $14.0M.

Web traffic of Solasta Bio

The website of Solasta Bio (solastabio.com) receives about 2.3K visits a month.

  • Monthly visits
    2.3K

    ▲ 111.5% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Solasta Bio

Premium access

Complete news archive for Solasta Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solasta Bio

Solasta Bio was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Solasta Bio is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.

Shireen Davies is the CEO of Solasta Bio, as recorded in our data. They have also founded this company.

Solasta Bio is a funded company, having raised a total of $20.76M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.8M, raised on Aug 2021.

Solasta Bio has 19 employees.

Solasta Bio was founded in 2020 in Glasgow, United Kingdom. Operations focus on the biotechnology sector for agriculture. Insect control peptides are developed to disrupt functions in target pest species. Beneficial insects and vertebrates are left unaffected by these solutions. Pest control services and related inputs are offered through this platform to support sustainable management practices.

Solasta Bio has 13 investors. Key investors include University of Glasgow, Corteva Agriscience, Scottish Enterprise, UPL, and FMC Corporation.

Solasta Bio operates through Solasta Bio Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available